|
Volumn 8, Issue 1, 2001, Pages 105-111
|
Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CD4 IMMUNOGLOBULIN;
GLYCOPROTEIN;
PEPTIDE;
PLASMA PROTEIN;
PROTEIN;
ARTICLE;
AUTOIMMUNE DISEASE;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DISEASE COURSE;
DRUG EFFICACY;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
MASS SPECTROMETRY;
PEPTIDE MAPPING;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
RHEUMATOID ARTHRITIS;
SILVER STAINING;
SYNOVIAL FLUID LEVEL;
TWO DIMENSIONAL GEL ELECTROPHORESIS;
ACUTE-PHASE PROTEINS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD4;
ARTHRITIS, RHEUMATOID;
ELECTROPHORESIS, GEL, TWO-DIMENSIONAL;
FEASIBILITY STUDIES;
HUMANS;
IMMUNOGLOBULINS;
IMMUNOTHERAPY;
PROTEINS;
SYNOVIAL FLUID;
|
EID: 0035161905
PISSN: 1071412X
EISSN: None
Source Type: Journal
DOI: 10.1128/CDLI.8.1.105-111.2001 Document Type: Article |
Times cited : (37)
|
References (32)
|